BioAlliance Pharma Announces that Therabel launches Loramyc® in Germany With the Support of Hikma Pharmaceuticals

PARIS--(BUSINESS WIRE)--Regulatory News:BioAlliance Pharma SA (Euronext Paris: BIO), a company dedicated to specialty and orphan pharma products in oncology and supportive care, today announced that Loramyc® has been launched in Germany by its European partner Therabel. Therabel has created a fully dedicated team and has also entered into a co-promotion agreement with Hikma Pharma GmbH, a leading specialty pharmaceutical group focused on branded and generic products in Oncology.